Semaglutide (Ozempic®, Wegovy® and similar brands) — Patient Guide for Australia

Semaglutide is a medicine used to help with blood sugar control in adults with type 2 diabetes and to support weight management in adults who meet specific criteria in Australia. It belongs to a group of medicines called GLP‑1 receptor agonists.

This guide explains how semaglutide works, how it’s used, what to expect, and important safety information. It is written for patient understanding and does not replace advice from your healthcare professional.

1) Basic product information

• Generic name: Semaglutide
• Medicine type: GLP‑1 receptor agonist (incretin-based therapy)
• Common formulations in Australia:
  • Subcutaneous injection (under the skin)
  • Brand examples that may be available include Ozempic® and Wegovy® (availability depends on product supply and PBS/eligibility where relevant)
• How it is taken: Usually once weekly by injection
• Typical setting: Used alongside diet and exercise

Your exact brand, dose, and injection schedule will depend on whether you’re using semaglutide for diabetes or for weight management, as well as your individual response and tolerance.

2) Mechanism of action (how semaglutide works)

Semaglutide mimics a natural hormone called glucagon-like peptide-1 (GLP‑1). GLP‑1 helps regulate appetite and blood sugar after meals.

Key actions include:

• Improves blood sugar control by increasing insulin release when glucose levels are high.
• Reduces glucagon (a hormone that raises blood sugar), helping stabilise glucose levels.
• Slows stomach emptying, which can reduce post-meal glucose spikes and increase fullness.
• Reduces appetite by acting on brain pathways involved in hunger.

Because semaglutide works in a glucose-dependent way, it generally has a lower risk of causing low blood sugar when used alone, compared with some other diabetes medicines. However, the risk can increase if combined with therapies that can cause hypoglycaemia (e.g., insulin or certain sulfonylureas).

3) Pharmacokinetics (what the body does with it)

“Pharmacokinetics” describes how semaglutide is absorbed, distributed, metabolised, and eliminated.

• Absorption: After a subcutaneous injection, semaglutide is absorbed gradually.
• Half-life: Semaglutide has an extended half-life, which supports once-weekly dosing.
• Time to effect: Many people notice reduced appetite within days, while blood sugar and weight changes typically build over weeks.
• Metabolism and clearance: Semaglutide is processed and eliminated through natural body pathways; exact processes are complex, but clinical dosing adjustments are usually not required for mild-to-moderate kidney or liver issues (your clinician will advise based on your situation).

Important practical implication: if you miss a dose, the timing guidance below helps maintain effectiveness while reducing side effects.

4) Typical uses in Australia

Semaglutide is used for:

• Type 2 diabetes: To improve glycaemic control in adults as part of a broader management plan (diet, activity, and other diabetes medicines if needed).
• Weight management: To support weight loss in adults who meet established criteria (for example, obesity or overweight with weight-related complications). Eligibility and brand indications depend on local guidance and product approvals.

Your clinician will determine which indication applies to you and which semaglutide brand/dose is appropriate.

5) How to take semaglutide: timing and routine

When to inject

• Once weekly: Semaglutide is typically injected on the same day each week.
• Any time of day: You can choose a convenient time. Consistency helps you remember your schedule.
• Can be taken with or without food: There’s no strict requirement for fasting.

Starting dose and dose increases

Most people begin with a lower “starter” dose to reduce the risk of nausea and gastrointestinal upset. The dose is then increased gradually based on tolerance and treatment goals.

Do not increase the dose faster than instructed. If side effects are bothersome, your clinician may slow the titration or pause escalation.

If you miss a dose (general guidance)

Because product directions can vary by brand strength and local protocol, always follow the instructions supplied with your specific pen. In general, once-weekly GLP‑1 therapies have a “missed dose” window where you take it as soon as possible if it’s not too close to the next dose.

• Check the product leaflet for your exact missed-dose rule.
• If you’re unsure, contact a healthcare professional or pharmacist for clarification.

6) Food interactions (what to know about meals)

Semaglutide is not known for dangerous direct food interactions, but it can affect how your stomach handles food.

Common meal-related effects

• Early fullness and reduced appetite can occur, especially during dose escalation.
• Nausea may be more likely if meals are large or high in fat.
• Reflux or indigestion can occur in some people due to slowed gastric emptying.

Practical nutrition tips

• Choose smaller, more frequent meals during the first weeks.
• Eat slowly and stop when you feel comfortably full.
• Limit very greasy or heavy meals if they trigger nausea.
• Stay hydrated—especially if you have vomiting or diarrhoea.

7) Alcohol interactions and cautions

There’s no universal “absolute” contraindication to alcohol with semaglutide, but alcohol can increase the risk of dehydration and can worsen nausea in some people.

• If you drink alcohol, consider smaller amounts at first and monitor how you feel.
• Avoid alcohol if you have persistent vomiting, significant diarrhoea, or feel unwell.
• If you have diabetes, be mindful that alcohol can affect blood glucose and may increase hypoglycaemia risk—particularly if you use other glucose-lowering medicines.

Ask your clinician for personalised guidance if you have liver disease, pancreatitis history, or frequent gastrointestinal symptoms.

8) Medicine interactions (including common diabetes medicines)

Semaglutide can influence appetite and digestion; it may indirectly affect how other medicines are absorbed (particularly those taken orally). It can also change blood sugar levels, affecting the need for dose adjustments of other glucose-lowering therapies.

Medicines that may require extra attention

• Insulin: Using semaglutide with insulin may increase the risk of hypoglycaemia, depending on doses.
• Sulfonylureas (e.g., glipizide, gliclazide, glimepiride): These can cause hypoglycaemia; combined therapy may require dose adjustments.
• Oral medicines needing tight glucose control: Your clinician may monitor you more closely during dose changes.
• Diuretics and blood pressure medicines: If you experience dehydration from gastrointestinal side effects, blood pressure can be affected.
• Warfarin: Some GLP‑1 therapies have led to changes in INR in certain patients; more frequent monitoring may be needed.

How to reduce interaction risk

• Tell your pharmacist or clinician about all medicines you take, including over-the-counter products and supplements.
• Keep a current list and update it at each appointment.
• Do not stop or change doses of other medicines without professional advice.

9) Indications (who semaglutide is for)

Semaglutide is indicated for specific conditions based on Australian approvals and product information. Common indications include:

• Type 2 diabetes (adults): To improve glycaemic control when used as part of a comprehensive diabetes care plan.
• Chronic weight management (adults): For weight loss and weight management in people who meet criteria for obesity and related complications, under guidance consistent with Australian product information and healthcare standards.

Your clinician will confirm suitability based on medical history, current medicines, and any risk factors.

10) Dosing and strength overview (patient-friendly)

Doses vary by brand and indication. In general, semaglutide is titrated gradually from lower doses to reduce side effects.

Typical approach:

• Start low for better tolerance.
• Increase stepwise according to a schedule provided by your clinician or the product instructions.
• Maintain the best tolerated effective dose long term if appropriate.

The table below provides a general overview of dose escalation concepts rather than a substitute for your specific pen’s instructions.

Important: Always use the dose and pen strength that matches your prescription/plan and pen instructions. Do not combine pen products or self-adjust dosing.

11) Safety profile: common and serious side effects

Like all medicines, semaglutide can cause side effects. Many are gastrointestinal and often improve as your body adjusts.

Common side effects

• Nausea
• Vomiting
• Diarrhoea or constipation
• Abdominal discomfort or bloating
• Decreased appetite
• Heartburn/reflux in some people
• Fatigue in some people

Serious warnings (seek urgent medical attention)

Stop taking the medicine and seek urgent advice if you experience:

• Symptoms of pancreatitis: severe persistent abdominal pain (often radiating to the back), with or without vomiting.
• Allergic reaction: swelling of the face/lips, difficulty breathing, widespread rash, or severe skin reactions.
• Signs of dehydration due to persistent vomiting/diarrhoea: dizziness, fainting, very dark urine, reduced urination.

Low blood sugar risk

• Semaglutide alone has a lower risk of hypoglycaemia.
• Risk can be higher if you use insulin or a sulfonylurea. You may need closer glucose monitoring and possible dose adjustments of those medicines.

Gallbladder issues

Rapid weight loss and GLP‑1 therapies have been linked with gallbladder problems in some patients. Seek medical advice if you develop:

• severe right upper belly pain
• pain after meals
• yellowing of the skin/eyes (jaundice)
• fever

Kidney considerations

If you become dehydrated from gastrointestinal side effects, kidney function can be affected. Maintain hydration and seek advice if you cannot keep fluids down.

12) Practical use tips for best results

Injection basics

• Semaglutide is injected under the skin (subcutaneous).
• Common injection sites include the abdomen, thigh, and upper arm.
• Rotate injection sites to reduce irritation.

Manage nausea and appetite changes

• Eat smaller meals and avoid lying down right after eating if you get reflux.
• Consider bland, low-fat foods during early adjustment.
• Track which foods worsen symptoms and limit those foods.
• Tell your clinician if nausea is significant—dose adjustment may be considered.

Hydration and constipation

• Drink water regularly.
• Increase fibre gradually if you experience constipation (unless you’ve been told to restrict fibre).
• Gentle activity like walking can help bowel movements.

Consistency matters

• Use the same weekly day when possible.
• Set a reminder on your phone or calendar.
• Keep notes of your dose and any side effects to discuss with your clinician.

13) Alternative options for diabetes and weight management

If semaglutide isn’t suitable or you need an alternative, options may include other medicines or lifestyle-based strategies. Choices depend on your condition, medical history, and access.

For type 2 diabetes

• Other GLP‑1 receptor agonists (injectable or oral options depending on availability)
• DPP‑4 inhibitors
• SGLT2 inhibitors
• Metformin (often first-line where appropriate)
• Insulin or other glucose-lowering therapies when needed

For weight management

• Other anti-obesity medicines (as approved in Australia)
• Structured diet and physical activity programmes
• Behavioural support (e.g., addressing eating patterns and routines)
• Bariatric procedures for certain patients under specialist care

Ask your healthcare professional about what fits your health goals, side-effect tolerance, and eligibility criteria.

14) Market and legal context for Australia (availability, approvals, and guidance)

In Australia, semaglutide-containing medicines are regulated by the Therapeutic Goods Administration (TGA). Availability to patients may also be influenced by prescribing arrangements and, for eligible people, Pharmaceutical Benefits Scheme (PBS) criteria and brand-specific listing.

Brand availability, indications, and subsidy status can change over time. Your pharmacist can help confirm what is currently available and the most appropriate option for your situation.

Recent guidance themes (high-level)

• Emphasis on gradual dose escalation to minimise gastrointestinal side effects.
• Monitoring of glucose levels if used alongside insulin or sulfonylureas.
• Patient selection and ongoing assessment of benefit versus tolerability.
• Safety awareness for dehydration and pancreatitis symptoms.

For the most up-to-date clinical guidance, your healthcare professional will refer to current product information and Australian evidence-based practice.

15) Delivery, storage, and availability (online pharmacy considerations)

Delivery and product availability

• Availability can vary due to supply, demand, and brand-specific stock.
• Delivery times depend on your location and courier schedules.
• Orders are typically dispatched promptly once stock is confirmed.

Storage requirements

Storage instructions depend on the exact brand and pen. In general, follow the product label for:

• Temperature requirements (some formulations require refrigeration; others may have room-temperature allowances for a limited period)
• Protection from light
• Keeping the pen use-by and batch information for safety tracking

Do not use expired medicine

• Check expiry dates before use.
• If the pen appears damaged or has been stored improperly, consult your pharmacist before using.

16) FAQ — Semaglutide in Australia

How long does semaglutide take to work?

Many people notice appetite changes within the first days to weeks. Blood glucose improvements and weight changes usually develop progressively over several weeks as your dose increases and your routine settles.

Can I take semaglutide with food?

Yes. Semaglutide can be taken with or without food. However, because it slows stomach emptying, large or high-fat meals may worsen nausea—especially during the dose-escalation period.

What should I do if I feel sick after my injection?

Mild stomach upset can be common, particularly at the beginning or after a dose increase. Focus on hydration, smaller meals, and avoiding triggers like fatty foods. If symptoms are severe, persistent, or you cannot keep fluids down, contact a healthcare professional promptly.

Does semaglutide cause low blood sugar?

The risk is lower when semaglutide is used alone. If combined with insulin or sulfonylureas, hypoglycaemia can occur—sometimes requiring monitoring and adjustment of those medicines.

What are the most common side effects?

The most common are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These often improve as your body adjusts.

Can I drink alcohol while on semaglutide?

Small amounts may be acceptable for some people, but alcohol can worsen nausea and increase dehydration risk. If you have diabetes, remember alcohol can also affect blood glucose.

Are there any foods I must avoid?

No specific “forbidden” foods are universally required. Practically, smaller meals and lower-fat choices may reduce nausea and reflux.

What if I need to change my injection day?

You may be able to shift your injection day with specific timing rules. Check your product leaflet and ask a pharmacist for advice so you avoid taking doses too close together.

Is semaglutide safe for everyone?

Not necessarily. Suitability depends on your medical history, risk factors, current medications, and tolerance. Your clinician will assess whether semaglutide is appropriate and monitor you during treatment.

What happens if I stop semaglutide?

Stopping may lead to gradual loss of the medication’s benefits on appetite, weight, and glucose levels. Decisions about stopping should be made with your healthcare professional.

How should I store semaglutide at home?

Follow the storage instructions on your specific pen label. Storage needs can differ by brand and formulation. Keep it out of reach of children and use it before the expiry date.

17) When to seek medical advice urgently

Seek urgent medical attention if you experience:

• severe persistent abdominal pain (possible pancreatitis)
• signs of an allergic reaction (swelling, breathing difficulty, widespread rash)
• persistent vomiting/diarrhoea leading to dehydration
• symptoms of gallbladder problems (severe right-sided abdominal pain, fever, jaundice)
• symptoms of very low blood sugar, especially if using insulin or sulfonylureas

Reminder: This information is general. Your exact semaglutide brand, dose, and timing plan should follow the instructions provided with your medicine and guidance from your healthcare professional.